Inactive Instrument
Mymetics Corporation Stock Other OTC
Stocks
MYMX
US62856A1025
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 439K 378K 355K 324K 608K 41.75M 613K 4.2M 1.64M 21.17M 1.65M 1.61M 70.1M | P/E 2021 |
-1.86x | P/E 2022 | -1.77x |
|---|---|---|---|---|---|
| Enterprise Value | 72.12M 62.1M 58.31M 53.23M 99.99M 6.86B 101M 691M 269M 3.48B 271M 265M 11.52B | EV / Sales 2021 |
177x | EV / Sales 2022 | 78x |
| Free-Float |
99.88% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -10.24% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 19/11/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.24% | +8.79% | - | - | 45 | |
| -1.66% | -4.96% | +49.84% | +88.43% | 68.13B | |
| +0.43% | +1.76% | +45.16% | +89.20% | 63.6B | |
| +1.31% | +1.81% | +37.52% | +12.07% | 25.57B | |
| +2.77% | -1.74% | -16.16% | +456.51% | 26.6B | |
| -0.46% | -9.94% | +0.98% | -15.98% | 25.52B | |
| -9.71% | -0.36% | +245.87% | +377.68% | 18.23B | |
| -0.64% | -0.05% | +28.68% | -20.04% | 19.69B | |
| -1.49% | -6.35% | +0.78% | +540.26% | 15.16B | |
| +0.35% | +0.16% | +46.96% | +144.04% | 13.54B | |
| Average | -1.93% | -2.71% | +48.85% | +185.80% | 30.67B | |
| Weighted average by Cap. | -0.72% | -2.34% | +45.34% | +146.26% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 430K 370K 348K 317K 596K 40.91M 600K 4.12M 1.6M 20.75M 1.61M 1.58M 68.7M | 1.03M 885K 831K 759K 1.43M 97.81M 1.44M 9.85M 3.83M 49.6M 3.86M 3.78M 164M |
| Net income | -4.73M -4.07M -3.82M -3.49M -6.56M -450M -6.6M -45.31M -17.63M -228M -17.76M -17.37M -756M | -4.8M -4.14M -3.88M -3.55M -6.66M -457M -6.71M -46.03M -17.91M -232M -18.04M -17.65M -768M |
| Net Debt | 67.1M 57.77M 54.25M 49.52M 93.03M 6.38B 93.69M 643M 250M 3.24B 252M 246M 10.72B | 71.68M 61.72M 57.95M 52.9M 99.38M 6.82B 100M 687M 267M 3.46B 269M 263M 11.45B |
Employees
-
